Dimephosphone solution for oral administration and external use 15%, 100ml

Inside, as part of complex therapy : traumatic brain injury, postoperative neurosurgical operations, Meniere's disease, postresuscitation syndrome, respiratory failure in infectious and inflammatory diseases (ARVI, influenza, tuberculosis, pneumonia, etc.), as well as in the treatment of conditions accompanied by acidosis ...
Outwardly : wounds, trophic ulcers, erysipelas, burns, prevention of pyoinflammatory complications in the places where the wires of the Ilizarov apparatus exit.

Inside - after meals with water. Adults 15-25 ml 3-4 times a day. Children 1-1.5 ml for every 5 kg of the child's body weight 3-4 times a day.
Outwardly, it is applied to a bandage, tampons, turundas and gauze wipes, daily for 3-14 days. When the Ilizarov apparatus is applied, gauze napkins with Dimephosphone are applied daily to the area of ??the needles exit for 7-14 days.
With erysipelas - lubricate the area of ??inflammation 3 times a day for 3-5 days.

Active substance : dimethyloxobutylphosphonyldimethylate 150 g.
Excipients : purified water up to 1 liter.

Hypersensitivity

epilepsy,

chronic renal failure of 2-3 degrees.

Trade name of the drug : DIMEFOSPHONE

International Non-Proprietary Name (INN) : Dimethyloxobutylphosphonyldimethylate

Dosage form : oral solution

Composition :
Active substance : dimethyloxobutylphosphonyldimethylate 150 g.
Excipients : purified water up to 1 liter.

Description : colorless or yellowish, transparent or opalescent liquid with a peculiar odor.

Pharmacotherapeutic group : antiacidotic
ATX code V03AX

PHARMACOLOGICAL PROPERTIES
Normalizes the acid-base state in acidosis of various etiologies. The antiacidotic effect is realized due to the intensification of the renal and pulmonary mechanisms of regulation of the acid-base state, increased intraorgan blood flow and tissue metabolism. Shows membrane stabilizing and anti-inflammatory effects. When applied externally, it has an antiseptic effect, increases the protective functions of the skin and mucous membranes.

Indications for use
Inside, as part of complex therapy : traumatic brain injury, postoperative period of neurosurgical operations, Meniere's disease, postresuscitation syndrome, respiratory failure in infectious and inflammatory diseases (ARVI, influenza, tuberculosis, pneumonia, etc.), as well as during therapy conditions accompanied by acidosis.
Outwardly : wounds, trophic ulcers, erysipelas, burns, prevention of pyoinflammatory complications in the places where the wires of the Ilizarov apparatus exit.

Contraindications :
hypersensitivity, epilepsy, chronic renal failure of 2-3 degrees.

Method of administration and dosage :
Inside - after meals with water. Adults 15-25 ml 3-4 times a day. Children 1-1.5 ml for every 5 kg of the child's body weight 3-4 times a day.
Outwardly, it is applied to a bandage, tampons, turundas and gauze wipes, daily for 3-14 days. When the Ilizarov apparatus is applied, gauze napkins with Dimephosphone are applied daily to the area of ??the needles exit for 7-14 days.
With erysipelas - lubricate the area of ??inflammation 3 times a day for 3-5 days.

Side effects :
Dyspeptic symptoms, drowsiness.

Overdose
Increase in the severity of side effects. Treatment - gastric lavage, activated carbon, symptomatic therapy.

Interaction with other medicinal products
Strengthens the antiplatelet effect of acetylsalicylic acid.

Release form
15% oral solution in 100 ml orange glass vials.
A bottle with instructions for use in a cardboard box.

Storage conditions : Store
in a cool, dark place, out of reach of children.

Expiration date :
3 years. Do not use later than the date indicated on the package.

Pharmacy Dispensing Terms :
Prescription